Atlas Trials

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

Clinical trial NCT07355335 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07355335
Sponsor
Massachusetts General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
KMT2A-rearrangedNPM1-mutant Refractory or Relapsed AML
Start date
2026-07-09
Primary completion
2027-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.